DocuSign (NASDAQ: DOCU) was one of the best-positioned companies to benefit from the pandemic. The company's e-signature platform boomed as industries that had resisted the technology had little ...
Docusign is a compelling 'growth at a reasonable price' play, benefiting from a strong Q2 beat, raised guidance, and improving sales execution. The company’s turnaround is evident in rebounding ...
DocuSign posted revenue and earnings growth, beating estimates. The company's free cash flow fell slightly, and its full-year forecast underwhelmed investors. DocuSign has steadied itself, but ...
DocuSign's stock has surged over 40% since November, driven by M&A speculation and interest from private equity buyers. The company remains attractive even without a buyout offer, with strong ...
This side-by-side comparison of Adobe Sign and DocuSign will help you make an informed decisions based on features, pricing, pros and cons. E-signature solutions like Adobe Sign and DocuSign have ...
DocuSign (Nasdaq: DOCU) is mid-transformation from e-signature to Intelligent Agreement Management (IAM). Q1 FY26 delivered 8% revenue growth to $764M and non-GAAP EPS of $0.90, with operating margin ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results